Hims & Hers Health launched its Australian operations on September 1, 2026. This expansion marks the company’s first entry into the Asia-Pacific market. The move follows the acquisition of Australian digital health firm Eucalyptus Health.
Initial services include men’s health treatments and branded GLP-1 weight-loss medications. Hims & Hers will rebrand the Pilot men’s health line under the Hims name. The company intends to launch women’s health services via the Juniper brand later this year.
The Australian model uses branded GLP-1 products rather than the compounded versions used in the U.S. This strategy shifts the company’s margin structure and regulatory profile in the new market.